Vigna Law Group: Trial Work Product Critical in Depo-Provera Cases

Greg Vigna, MD, JD

Greg Vigna, MD, JD

Vigna Law Group seeks Depo-Provera complaint files as key trial evidence in meningioma litigation.

Nothing is more important than how a pharmaceutical company handles the first reported serious risk.”
— Greg Vigna, MD, JD

LOS ANGELES, CA, UNITED STATES, August 21, 2026 /EINPresswire.com/ -- “Putting together a trial work product requires this important discovery. My firm does this work, and we have asked for them through the California JCCP because, to our knowledge, these documents to date have not been provided for the Multidistrict Litigation,” states Greg Vigna, MD, JD, and national neurological injury attorney.

Dr. Greg Vigna, MD, JD, continues, "Nothing is more important than how a pharmaceutical company handles the first reported serious risk. In the Cook IVC litigation, it was a far-reaching perforation of the filter into adjacent arteries by Dr. Sadaf. I reviewed every adverse event in that litigation for the purpose of understanding internal communications that describe knowledge and conduct.”

Read Sadaf, “Significant Caval Penetration by the Celect Inferior Vena Cava Filter: Attributable to Filter Design?”, published in 2007 in the Journal of Vascular and Interventional Radiology: https://www.jvir.org/article/S1051-0443(07)01022-6/abstract

Dr. Vigna explains, “Internal documents of adverse events are essential in trials. By going to trial, internal confidential documents become public. As in the Cook IVC litigation, when physician experts learn about the documented challenges of a pharmaceutical company medical articles are written to analyze such situations.”

Read “Lessons From Celect: Building Transparency and Trust in Medical Devices”, published in JACC Journals, Archives. Vol. 85, No. 10: https://www.jacc.org/doi/full/10.1016/j.jacc.2025.01.002

Dr. Vigna concludes, “My firm, with other firms in the JCCP, is doing the work to understand knowledge of Upjohn, Pharmacia, and Pfizer, and that is by way of the internal documents from the complaint files that might include meningioma. Other discovery is being provided, because we have Bellwethers that need to be heard.”

Dr. Vigna is a California attorney and a Washington, DC, attorney, with an office in Connecticut. He is a pharmaceutical injury attorney and represents women with Depo-Provera claims filed in state court in California, Washington, Wisconsin, Minnesota, and Connecticut, and represents women in the Depo-Provera Multi-District Litigation in Florida, and Co-Counsels with Ben Martin Law Group, a national pharmaceutical injury attorney, in Dallas, Texas.

Relevant Case Numbers:
California Bellwether selections represented by the Vigna Law Group: California Case No. 26CV189984, Case No. 26CV179081, Case No. 26CV178116, Case No. 26CV179212

Discover crucial insights by watching Dr. Vigna’s educational episode on Justice with Dr. V. He is an expert in brain injuries and a personal injury and pharmaceutical injury attorney. This two-minute explainer delves into the symptoms associated with Depo-Provera and meningiomas, providing essential information to guide your health decisions.

Watch Justice with Dr.V on TikTok to learn more about Depo-Provera.

Dr. Vigna is a California and Washington, D.C., attorney who is active in the Depo-Provera litigation and has cases filed in Minnesota, Connecticut, California, New Hampshire, Wisconsin, Washington, and in the Multidistrict Litigation with the Ben Martin Law Group.


Greg Vigna, MD, JD
Vigna Law Group
California Offices:
8939 S. Sepulveda Blvd., Suite 102, Los Angeles, CA 90045
2570 N. First Street, 2nd Floor, San Jose, CA 95131
931 10th Street, #962, Modesto, CA 95354
2281 Lava Ridge Court, Suite 200, Roseville, CA 95661
600 West Broadway, Suite 700, San Diego, CA 92101

Connecticut Office:
515 Centerpoint Drive, Suite #2212, Middletown, CT 06457

Greg Vigna, MD, JD
Vigna Law Group
+1 817-809-9023
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

Depo-Provera & Meningioma Risk: What the FDA Warning Means

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Minnesota Daily Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.